2024
Correction: Randomised phase II trial of weekly ixabepilone 卤 biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
British journal of cancer
鈥�Research at a glance
Top areas of exploration
- Pregnancy , 14 publications
- Cell Line, Tumor , 10 publications
- Uterine Neoplasms , 8 publications
- Neoplasm Recurrence, Local , 7 publications
Research activity
My publications
Filter publications
81 publications
2022
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Cancer
鈥�2022
Alterations in Pre/Post Oxygenator Flows Due to Fibrin Deposition in the CardioHelp System-A Case Report.
The journal of extra-corporeal technology
鈥�2022
Randomised phase II trial of weekly ixabepilone鈥壜扁�塨iweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
British journal of cancer
鈥�2021
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).
Annals of oncology : official journal of the European Society for Medical Oncology
鈥�